Na Li
- Molecular Biology top 5%
- Epidemiology top 2%
- Cancer Research top 1%
- Surgery top 5%
- Immunology top 5%
- Topics
- Autophagy in Disease and Therapy (33 papers)MicroRNA in disease regulation (26 papers)Liver Disease Diagnosis and Treatment (26 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Na Li
274 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 149
- Molecular Biology 2.4k
- Epidemiology 1.4k
- Cancer Research 1.3k
- Surgery 876
- Immunology 850
Countries citing papers authored by Na Li
This map shows the geographic impact of Na Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Li more than expected).
Fields of papers citing papers by Na Li
This network shows the impact of papers produced by Na Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Li. The network helps show where Na Li may publish in the future.
Co-authorship network of co-authors of Na Li
This figure shows the co-authorship network connecting the top 25 collaborators of Na Li. A scholar is included among the top collaborators of Na Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Li. Na Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 24 | |
| 10 | 12 | |
| 11 | 2 | |
| 12 | 24 | |
| 13 | 139 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 75 | |
| 17 | 50 | |
| 18 | 22 | |
| 19 | 1 | |
| 20 | 2 |
About Na Li
Na Li is a scholar working on Epidemiology, Cancer Research and Geriatrics and Gerontology, having authored 303 papers that have together received 6.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (33 papers), MicroRNA in disease regulation (26 papers) and Liver Disease Diagnosis and Treatment (26 papers). The work is most often cited by research in Cancer Research (1.3k citations), Geriatrics and Gerontology (297 citations) and Epidemiology (1.4k citations). Na Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xuhu Mao, Quanming Zou, Bin Xiao, Bo–Sheng Li, Endong Zhu, Yuan Zhuang, Bin Tang, Bin Tang, Peili Bu and Tongshuai Chen. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.